Related Experiment Video
Updated: Jun 28, 2026
09:04
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
[Endocannabinoid system and bowel inflammation].
Lucía Márquez1, Sergio Abanades, Montserrat Andreu
1Servei d'Aparell Digestiu, Hospital del Mar, Universidad Autónoma de Barcelona, Barcelona, Spain.
Medicina Clinica
|November 15, 2008
Summary
The endocannabinoid system, with CB1 and CB2 receptors, regulates gastrointestinal functions and inflammation. Research into this system offers potential therapeutic advancements for inflammatory bowel disease.
Area of Science:
- Gastroenterology
- Immunology
- Endocrinology
Context:
- The endocannabinoid system (ECS) is a vital regulatory network present in all vertebrates.
- It comprises specific receptors, primarily CB1 and CB2, mediating cannabinoid effects.
- CB1 receptors are found in the gastrointestinal tract, influencing motility, while CB2 receptors modulate immune cell activity.
Purpose:
- To explore the role of the endocannabinoid system in gastrointestinal function and inflammation.
- To investigate the immunomodulatory effects of CB2 receptor activation.
- To understand the potential therapeutic applications of the ECS in inflammatory bowel disease (IBD).
Summary:
- CB1 receptors in the gut impact peristalsis and contractions.
- CB2 receptors on immune cells reduce pro-inflammatory cytokine release, suggesting an anti-inflammatory role.
- The ECS plays a significant role in maintaining homeostasis, particularly in inflammatory conditions.
Impact:
- Understanding ECS mechanisms in the GI tract can lead to novel therapeutic strategies for IBD.
- Targeting the endocannabinoid system may offer a new approach to managing gut inflammation.
- Further research can elucidate the full therapeutic potential of cannabinoids in gastrointestinal disorders.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:17Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...